The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Results seem OK, but there are headwinds to face to impact future despite easing of restrictions for on-trade sales. Good to see the dividend lifted.
There are up days and down ones. Same with weeks and months. In my experience September is a flat or down month and October a flat or up month. I am not fussed with interday or interweek movement but I do look at my portfolio on a monthly basis so that any dividends accumulated are invested every 6 months or so.
The advantage with news is that it provides information for a more level playing field to asses if the market valuation immediately before news is accurate. What I might interpret as good news and prospects might have fallen short of market opinion to see the share price fall. And although is disheartening might provide a good opportunity to deal in the shares.
In the old days, AGM’s were a great opportunity to discover what competitors were up to and questions were couched for more detailed replies than the stock answers from the briefing team had designed and usually included information inadvertenly disclosed.
Hope this share goes up this week , doing well in America .
Anyone looked at EISB?
Look like a very decent competitor for fever in the long time. Good story. I’ve moved some profits from here into there
Hoping for a nice rising trend into to half year trading update
Be nice if the company put out some news on new partnerships etc as it is a quiet little stock this with only news posted in terms of market half yearly and yearly updates!! Shocking performance this year!
EISB are going to be huge in my view, a great growth strategy and delivering at pace already since listing.
So do you see selling at above £22 as sensible,or will Fevertree survive this new powerful competition. Others see the present sp as a buying oportunity !
Eisb looks amazing at 30mcap and it's coming to UK , fevertree is having a serious competition now imo
Top up time again, eventually the SP will shoot up, bargain price now. Charts look good.
I think sales and turnover going very well but the huge increases in costs and their effect on margins are preventing equivalent increases in profits and that is holding the price back as shares are already trading on a sky high multiple. i think shares will move upwards again as this is undoubtedly a quality company, but only when the cost pressures begin to abate. Hopefully there will be some evidence of that by year end.
Cannot understand why the share price has not yet shot up to £25 as everything in the company seems to be going well and its products are flying off the shelves
Yes an interesting share hopefully with I good future I am already in it
SP moving close to 2300 maybe buying in below that figure will soon be an option.
EISB is worth a look, looks like a junior Fevertree
https://investors.eastimperial.com/
" looking at the shelves in my supermarket their sales are booming"
Are they though? If the shares are empty, maybe that's a result of supply chain problems rather than booming sales, in which case that's a concern.
Tesco shelves are empty of milk - that's not because people are suddenly buying twice as much as normal.
Cannot understand why the share price has not gone up to £25 yet as restrictions relaxed and market strong and looking at the shelves in my supermarket their sales are booming
A buy bellow 2300. Think the market totally agrees so the sp will not go there
I'm doing my bit!
Repeat order for 64 bottles of Refreshingly Light Ginger Beer x 500ml placed today.
It's a buy on every dip below 2,300
I see Terry Smith has taken a 5.15% stake in Fevertree. Very good news indeed.
Hi all, I have written an article on the Fevertree Half Year update on my website. Includes results analysis, US grocery market research and updates financial estimates (EPS, Margins. (Available at TheTwentiesTrader.com)
For those interested in the sector EISB is a new list that IPO’d on Monday
A tiny minor to Fevertree but ‘could’ be the early stages of another great story
https://investors.eastimperial.com/
Seems the drop earlier this week was an overreaction compounded by poor market sentiment. Continued US growth is the key here